PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Ring, J. ; Alomar, A.* ; Bieber, T.* ; Deleuran, M.* ; Fink-Wagner, A.* ; Gelmetti, C.* ; Gieler, U.* ; Lipozencic, J.* ; Luger, T.* ; Oranje, A.P.* ; Schäfer, T.* ; Schwennesen, T.* ; Seidenari, S.* ; Simon, D.* ; Ständer, S.* ; Stingl, G.* ; Szalai, S.* ; Szepietowski, J.C.* ; Taïeb, A.* ; Werfel, T.* ; Wollenberg, A.* ; Darsow, U.

Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.

J. Eur. Acad. Dermatol. Venereol. 26, 1176-1193 (2012)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
The existing evidence for treatment of atopic eczema (atopic dermatitis, AE) is evaluated using the national standard Appraisal of Guidelines Research and Evaluation. The consensus process consisted of a nominal group process and a DELPHI procedure. Management of AE must consider the individual symptomatic variability of the disease. Basic therapy is focused on hydrating topical treatment, and avoidance of specific and unspecific provocation factors. Anti-inflammatory treatment based on topical glucocorticosteroids and topical calcineurin inhibitors (TCI) is used for exacerbation management and more recently for proactive therapy in selected cases. Topical corticosteroids remain the mainstay of therapy, but the TCI tacrolimus and pimecrolimus are preferred in certain locations. Systemic immune-suppressive treatment is an option for severe refractory cases. Microbial colonization and superinfection may induce disease exacerbation and can justify additional antimicrobial treatment. Adjuvant therapy includes UV irradiation preferably with UVA1 wavelength or UVB 311 nm. Dietary recommendations should be specific and given only in diagnosed individual food allergy. Allergen-specific immunotherapy to aeroallergens may be useful in selected cases. Stress-induced exacerbations may make psychosomatic counselling recommendable. Eczema school educational programs have been proven to be helpful. Pruritus is targeted with the majority of the recommended therapies, but some patients need additional antipruritic therapies.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
1.491
1.491
247
339
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Randomized Controlled-Trial; Placebo-Controlled Trial; Chinese Herbal Therapy; Evening Primrose Oil; Narrow-Band Uvb; Classical Homeopathic Treatment; Anti-Cd20 Rituximab Treatment; Parent-Child Relationships; Blind Controlled Trial; Necrosis-Factor-Alpha
Sprache englisch
Veröffentlichungsjahr 2012
HGF-Berichtsjahr 2012
ISSN (print) / ISBN 0926-9959
e-ISSN 1468-3083
Zeitschrift Journal of the European Academy of Dermatology and Venereology
Quellenangaben Band: 26, Heft: 9, Seiten: 1176-1193 Artikelnummer: , Supplement: ,
Verlag Wiley
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Allergy Research (IAF)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Allergy
PSP-Element(e) G-505400-001
PubMed ID 22813359
DOI 10.1111/j.1468-3083.2012.04636.x
WOS ID WOS:000307555400024
Scopus ID 84865085421
Erfassungsdatum 2012-09-21
[➜Korrektur melden]